NVCT Competitors & Alternatives
Compare Nuvectis Pharma Inc with similar stocks in the same industry
Biotechnology
NVCT
Main Stock$17.55
Tradestie Score
58
Market Cap
$154.27M
Analyst Upside
-0.9%
Top Competitors
224 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
DSGN
Design Therapeutics, Inc. Common Stock
|
$13.74
|
$386.68M | - | 54 | Compare |
|
AURA
Aura Biosciences, Inc. Common Stock
|
$7.02
|
$382.04M | - | 51 | Compare |
|
DRTS
Alpha Tau Medical Ltd. Ordinary Shares
|
$9.80
|
$371.64M | - | 53 | Compare |
|
CAPR
Capricor Therapeutics Inc
|
$29.60
|
$357.51M | - | 56 | Compare |
|
CGEM
Cullinan Therapeutics, Inc. Common Stock
|
$17.75
|
$354.45M | - | 60 | Compare |
|
LBRX
LB Pharmaceuticals Inc Common Stock
|
$30.60
|
$353.70M | - | 58 | Compare |
|
PROK
ProKidney Corp. Class A Ordinary Shares
|
$1.80
|
$350.98M | - | 62 | Compare |
|
ALT
Altimmune, Inc. Common Stock
|
$2.91
|
$341.56M | - | 59 | Compare |
|
ANNX
Annexon, Inc. Common Stock
|
$5.28
|
$332.96M | - | 53 | Compare |
|
REPL
Replimune Group, Inc.
|
$11.42
|
$328.62M | - | 63 | Compare |
More NVCT Analysis
Data updated: Jun 23, 2026 | Industry: Biotechnology (SIC 2834)
224 stocks in this industry